×
It looks like you're using an obsolete version of internet explorer. Internet explorer is no longer supported by Microsoft since the end of 2015. We invite you to use a newer browser such as Firefox, Google Chrome or Microsoft Edge.
My Player placeholder

Become an Oncostream member and receive full access to its content!

You must be an Oncostream member to access videos without any restrictions. Register for free in one minute and access all services provided by Oncostream.You will also be able to log into Oncostream from your Facebook or twitter account by clicking on login on the top-right corner of Oncostream website.

Registration Login


Worldwide schedules comment Share
21421 views

 

 

18:00
Introduction
Pr Jean-Marc Classe, Institut de Cancérologie de l’Ouest (ICO), Saint-Herblain
 
18:10
Actualités en hormonothérapie
Dr Thibault de la Motte Rouge, Centre Eugène Marquis, Rennes

18:35 Actualité en thérapies ciblées: l’évolution de la place des traitements néoadjuvants
Dr Dorothée Chocteau, Le Confluent, Institut Catherine de Sienne, Nantes
 
19:00 Actualités en radiothérapie
Dr Augustin Mervoyer, ICO, Saint-Herblain
 
19:25 Actualités en chirurgie
Dr Augustin Reynard, ICO, Angers
 
19:50 Résultats de l'étude RxPONDER chez les patientes HER2-, RH+, avec atteinte ganglionnaire
Dr Dorothée Chocteau, Le Confluent, Institut Catherine de Sienne, Nantes

 
20:10 Clôture de la soirée digitale

 

Shooting date : 2021-02-09
Last update : 2021-06-09

Suggestions

Thursday, October 14th 2021 from 06pm to 07pm (GMT+2)
Honolulu : Thursday, October 14th 2021 from 07am to 08am (GMT+2)
San Francisco : Thursday, October 14th 2021 from 10am to 11am (GMT+2)
New York : Thursday, October 14th 2021 from 01pm to 02pm (GMT+2)
Buenos Aires : Thursday, October 14th 2021 from 02pm to 03pm (GMT+2)
Reykjavik : Thursday, October 14th 2021 from 05pm to 06pm (GMT+2)
London / Dublin : Thursday, October 14th 2021 from 06pm to 07pm (GMT+2)
Paris / Berlin : Thursday, October 14th 2021 from 07pm to 08pm (GMT+2)
Istanbul : Thursday, October 14th 2021 from 08pm to 09pm (GMT+2)
Moscou / Dubaï : Thursday, October 14th 2021 from 09pm to 10pm (GMT+2)
Bangkok : Friday, October 15th 2021 from 12am to 01am (GMT+2)
Shanghai : Friday, October 15th 2021 from 01am to 02am (GMT+2)
Tokyo : Friday, October 15th 2021 from 02am to 03am (GMT+2)
Sydney : Friday, October 15th 2021 from 04am to 05am (GMT+2)
Wellington : Friday, October 15th 2021 from 06am to 07am (GMT+2)

Le cancer du sein métastatique HER2 +, standards actuels et orientations futures

Octobre Rose 2021

Share
Thursday, March 10th 2022 from 07pm to 09pm (GMT+1)
Honolulu : Thursday, March 10th 2022 from 08am to 10am (GMT+1)
San Francisco : Thursday, March 10th 2022 from 10am to 12pm (GMT+1)
New York : Thursday, March 10th 2022 from 01pm to 03pm (GMT+1)
Buenos Aires : Thursday, March 10th 2022 from 03pm to 05pm (GMT+1)
London / Dublin : Thursday, March 10th 2022 from 06pm to 08pm (GMT+1)
Paris / Berlin : Thursday, March 10th 2022 from 07pm to 09pm (GMT+1)
Istanbul : Thursday, March 10th 2022 from 08pm to 10pm (GMT+1)
Moscou / Dubaï : Thursday, March 10th 2022 from 10pm to 12am (GMT+1)
Bangkok : Friday, March 11th 2022 from 01am to 03am (GMT+1)
Shanghai : Friday, March 11th 2022 from 02am to 04am (GMT+1)
Tokyo : Friday, March 11th 2022 from 03am to 05am (GMT+1)
Sydney : Friday, March 11th 2022 from 04am to 06am (GMT+1)
Wellington : Friday, March 11th 2022 from 06am to 08am (GMT+1)

Changement de paradigme dans les cancers du sein triple négatif métastatique - de la théorie à l...

Share
Thursday, May 25th 2023 from 06:30pm to 08pm (GMT+2)
Honolulu : Thursday, May 25th 2023 from 07:30am to 09am (GMT+2)
San Francisco : Thursday, May 25th 2023 from 10:30am to 12pm (GMT+2)
New York : Thursday, May 25th 2023 from 01:30pm to 03pm (GMT+2)
Buenos Aires : Thursday, May 25th 2023 from 02:30pm to 04pm (GMT+2)
Reykjavik : Thursday, May 25th 2023 from 05:30pm to 07pm (GMT+2)
London / Dublin : Thursday, May 25th 2023 from 06:30pm to 08pm (GMT+2)
Paris / Berlin : Thursday, May 25th 2023 from 07:30pm to 09pm (GMT+2)
Istanbul : Thursday, May 25th 2023 from 08:30pm to 10pm (GMT+2)
Moscou / Dubaï : Thursday, May 25th 2023 from 09:30pm to 11pm (GMT+2)
Bangkok : Friday, May 26th 2023 from 12:30am to 02am (GMT+2)
Shanghai : Friday, May 26th 2023 from 01:30am to 03am (GMT+2)
Tokyo : Friday, May 26th 2023 from 02:30am to 04am (GMT+2)
Sydney : Friday, May 26th 2023 from 04:30am to 06am (GMT+2)
Wellington : Friday, May 26th 2023 from 06:30am to 08am (GMT+2)

Cancer du sein RH+ : Quelles optimisations thérapeutiques en 2L métastatique ?

Share
Thursday, February 1st 2024 from 06pm to 07:30pm (GMT+1)
Honolulu : Thursday, February 1st 2024 from 07am to 08:30am (GMT+1)
San Francisco : Thursday, February 1st 2024 from 09am to 10:30am (GMT+1)
New York : Thursday, February 1st 2024 from 12pm to 01:30pm (GMT+1)
Buenos Aires : Thursday, February 1st 2024 from 02pm to 03:30pm (GMT+1)
London / Dublin : Thursday, February 1st 2024 from 05pm to 06:30pm (GMT+1)
Paris / Berlin : Thursday, February 1st 2024 from 06pm to 07:30pm (GMT+1)
Istanbul : Thursday, February 1st 2024 from 07pm to 08:30pm (GMT+1)
Moscou / Dubaï : Thursday, February 1st 2024 from 09pm to 10:30pm (GMT+1)
Bangkok : Friday, February 2nd 2024 from 12am to 01:30am (GMT+1)
Shanghai : Friday, February 2nd 2024 from 01am to 02:30am (GMT+1)
Tokyo : Friday, February 2nd 2024 from 02am to 03:30am (GMT+1)
Sydney : Friday, February 2nd 2024 from 03am to 04:30am (GMT+1)
Wellington : Friday, February 2nd 2024 from 05am to 06:30am (GMT+1)

Prise en charge du cancer du sein métastatique HER2-faible

Cycle d'enseignement - Le cancer du sein

Share
Scroll Up